Please login to the form below

Not currently logged in
Email:
Password:

Ian Weatherhead joins Ipsen

Takes up corporate communications role at the French pharma firm

Ipsen Dr Ian WeatherheadFrench biopharmaceutical company Ipsen has appointed Ian Weatherhead as vice president, corporate external communications.

He brings 20 years of corporate communications experience within the life sciences sector, most recently at Teva UK/Ireland where he led its corporate communications and government affairs team.

Prior to that he held global, regional and affiliate roles with AstraZeneca, Syngenta, UCB and Sanofi.

In his new role at Ipsen Weatherhead will be responsible for the design and implementation of an external corporate communications strategy.

Reporting to senior vice president, public affairs and

corporate communications Didier Veron, Weatherhead will also oversee Ipsen’s media and public relations, digital communications, and corporate image and reputation.

Veron said: “I am delighted that Ian is joining the team to advance our external communications strategy as Ipsen continues its evolution into a leading global biopharmaceutical company focused on innovation and specialty care. He brings a wealth of experience in the pharmaceutical sector.”

13th September 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics